#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5730	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2414	551.9	0	.	n	.	0	C451T	SNP	451	451	C	711	711	T	694	T,C,A	341,280,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5730	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2414	551.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1444	1444	C	726	C,A,G	668,3,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5730	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2414	551.9	0	HET	.	.	.	C1269T,G	.	1269	1269	C	1529	1529	C	725	C,T,G	503,153,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5730	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2414	551.9	0	HET	.	.	.	C207T,G,A	.	207	207	C	467	467	C	560	C,T,G,A	388,104,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9560	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4234	536.3	0	.	n	.	0	T695C	SNP	695	695	T	1374	1374	C	670	C,A,T	589,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9560	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4234	536.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2650	2650	C	697	C,A,T	635,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9560	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4234	536.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2724	2724	A	658	A	609	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9560	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4234	536.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3276	3276	C	715	C,A	660,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	608	folP	855	855	100.0	folP.l6.c17.ctg.1	2000	73.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1279	1281	AGC	99;99;95	A;G,T;C	87;85,2;83	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1424	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3916	87.3	1	SNP	p	S91F	1	.	.	271	273	TTC	866	868	TTC	109;110;109	T;T;C	97;96;101	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1424	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3916	87.3	1	SNP	p	D95G	1	.	.	283	285	GGC	878	880	GGC	113;113;113	G;G;C	104;105;103	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1424	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3916	87.3	1	SNP	p	G95N	0	.	.	283	285	GGC	878	880	GGC	113;113;113	G;G;C	104;105;103	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	538	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1829	71.4	1	SNP	p	G45D	0	.	.	133	135	GGC	778	780	GGC	139;140;140	G,A;G;C	121,1;125;126	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	360	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1610	53.5	0	.	n	.	0	A197.	DEL	197	197	A	902	902	A	120	A	116	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1386	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3452	95.7	1	SNP	p	D86N	0	.	.	256	258	GAC	822	824	GAC	103;104;107	G;A,C;C,T	79;72,1;83,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1386	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3452	95.7	1	SNP	p	R87I	0	.	.	259	261	CGT	825	827	CGT	106;106;111	C,G;G,T;T,C	86,1;76,1;88,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1386	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3452	95.7	1	SNP	p	R87W	0	.	.	259	261	CGT	825	827	CGT	106;106;111	C,G;G,T;T,C	86,1;76,1;88,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1386	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3452	95.7	1	SNP	p	S87R	1	.	.	259	261	CGT	825	827	CGT	106;106;111	C,G;G,T;T,C	86,1;76,1;88,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1386	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3452	95.7	1	SNP	p	S88P	0	.	.	262	264	TCC	828	830	TCC	111;112;112	T,G;C,T;C,T,G	86,1;95,2;99,1,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1188	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3284	87.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1933	1935	GGC	90;90;91	G;G;C	81;80;72	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	1146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2666	101.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1502	1504	GCC	155;157;157	G,T;C;C,G,A	141,1;144;140,1,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2666	101.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1505	1507	ATG	158;158;157	A;T,G;G,T	145;144,1;145,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2666	101.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1517	1519	ACC	159;159;159	A,G;C,G;C	146,1;146,1;148	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2666	101.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1517	1519	ACC	159;159;159	A,G;C,G;C	146,1;146,1;148	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2666	101.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2018	2020	ACC	133;131;130	A;C,A;C	117;116,1;123	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2666	101.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2072	2074	GCG	113;113;113	G,T;C;G	103,1;91;98	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2666	101.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2072	2074	GCG	113;113;113	G,T;C;G	103,1;91;98	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2666	101.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2195	2197	GGT	102;101;101	G;G,T;T,G	97;93,3;95,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2666	101.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2204	2206	AGC	91;91;90	A,C;G,C;C,G	65,1;74,1;69,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2666	101.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2222	2224	CCG	78;76;76	C;C,G,A;G,C,T	71;63,1,1;65,2,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1736	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3677	111.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1849	1851	CCG	150;150;150	C,G,A;C,A,G;G,C	115,8,1;135,1,1;100,9	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	616	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2338	63.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	782	782	C	49	C	41	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	74	porB1a	984	252	90.23	porB1a.l15.c4.ctg.1	1122	15.7	0	.	p	.	0	H217N	NONSYN	649	651	CAT	895	897	AAT	11;11;11	A;A;T	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	74	porB1a	984	252	90.23	porB1a.l15.c4.ctg.1	1122	15.7	0	.	p	.	0	D218N	NONSYN	652	654	GAT	898	900	AAT	11;11;9	A;A;T	10;10;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	74	porB1a	984	252	90.23	porB1a.l15.c4.ctg.1	1122	15.7	0	.	p	.	0	V226A	NONSYN	676	678	GTA	922	924	GCA	5;5;5	G;C;A	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	74	porB1a	984	252	90.23	porB1a.l15.c4.ctg.1	1122	15.7	0	.	p	.	0	.	MULTIPLE	700	702	ACT	945	947	GTA	3;3;3	G;T;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	74	porB1a	984	252	90.23	porB1a.l15.c4.ctg.1	1122	15.7	0	.	p	.	0	N237fs	FSHIFT	709	709	A	954	954	A	3	A	3	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	824	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	2276	86.5	0	.	p	.	0	G256D	NONSYN	766	768	GGT	1382	1384	GAT	117;118;118	G;A;T	108;108;110	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	824	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	2276	86.5	1	SNP	p	G120K	1	.	.	358	360	AAG	974	976	AAG	120;120;122	A,C;A;G,A	106,5;113;111,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	824	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	2276	86.5	1	SNP	p	N121D	0	.	.	361	363	AAC	977	979	AAC	123;123;122	A,G;A;C,A	112,1;112;109,2	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	824	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	2276	86.5	1	SNP	p	A121N	1	.	.	361	363	AAC	977	979	AAC	123;123;122	A,G;A;C,A	112,1;112;109,2	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2988	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5356	133.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	452	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1599	68.6	1	SNP	p	V57M	1	.	.	169	171	ATG	839	841	ATG	148;145;145	A;T;G	133;134;134	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
